Stock listing

Delcath Systems, Inc.

Selected listing: DCTH · NASDAQ · USD · US

Delcath Systems, Inc. (NASDAQ:DCTH), Health Technology. Latest release Aug 6, 2026: Delcath Systems Reports Second Quarter 2026 Results and Business Highlights.

DCTH:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:DCTH
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: NASDAQ
Currency: USD

About Delcath Systems, Inc.

Delcath Systems, Inc. is a public company traded under the ticker DCTH in the American market. Delcath focuses on developing innovative therapies for cancer treatment.

Latest news from Delcath Systems, Inc.

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights

August 6, 2026

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

July 27, 2026

Delcath Systems to Host Second Quarter 2026 Earnings Call

July 23, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer

July 10, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

July 9, 2026

All Delcath Systems, Inc. news →

Events

Replays

Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:30 AM ET
Watch
Delcath Systems, Inc. (DCTH) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Delcath Systems, Inc. (DCTH) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 PM ET
Watch

Research Delcath Systems, Inc.

Delcath Systems, Inc. company profile

View the public company page for Delcath Systems, Inc. on 6ix.

Delcath Systems, Inc. news

Read company news and market updates connected to Delcath Systems, Inc..

Delcath Systems, Inc. investor events

Find investor webinars, events, and replay context for Delcath Systems, Inc..